STREAM (Standardized Treatment Regimen of Anti-TB Drugs for Patients with MDR-TB) Stage 1 demonstrated non-inferior efficacy of a shortened regimen (the Short regimen) for rifampicin-resistant TB (RR-TB) compared to the contemporaneous WHO-recommended regimen. This regimen included moxifloxacin and clofazimine, known to cause QT prolongation, and severe prolongation was more common on the Short regimen. This study investigated risk factors for QT prolongation with the Short regimen.
Recent Abstracts
Lessons from Vietnam’s Campaign for a Tax on Sugar-Sweetened Beverages
Principles of Alcohol Taxation
Public Attitudes Towards Alcohol Policy: South Africa
Quality Assurance and Improvement Framework for Medical Certification of Cause of Death and…
More Data Better Health: Climate and Health in the Legal Amazon
Mais Dados Mais Saúde: Clima e Saúde na Amazônia Legal
Health Taxes Action Guide
Opinión pública frente a la política de alcohol: Colombia
Public Attitudes Towards Alcohol Policy: Colombia
2024 Activity Report – Brazil